Two Ways Your RTSM System Can Unblind Your Clinical Trial

RTSM systems are often treated as a purely technical risk, but the real vulnerabilities frequently come down to people — their habits, their inboxes, and the everyday shortcuts that quietly open the door to unblinding. This clip breaks down the two most common paths that lead to accidental disclosure in a clinical study.

One pathway is widely recognized: direct access to treatment data through misconfigured permissions or improper system use. The other is far more subtle and far more common. It lives in routine email threads, exported spreadsheets, and status updates that seem harmless until they reveal more than intended.

Understanding both risks is essential for any study team aiming to protect integrity, maintain blinding, and avoid preventable deviations. This preview offers a clear, practical look at how unblinding really happens — and why safeguarding your study requires more than secure technology.

Watch the clip to see where vulnerabilities start and how to prevent them.